“Evaluation of the inhibitory effect of 2,5-Dimethyl-Celecoxib on tamoxifen-sensitive and -resistant human breast cancer cells (MCF-7)”, CMP, vol. 3, no. 1, Jan. 2026, doi: 10.70731/sh45n436.